John Kao Sells 180,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 180,000 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $21.11, for a total value of $3,799,800.00. Following the sale, the chief executive officer directly owned 2,832,641 shares of the company’s stock, valued at $59,797,051.51. This represents a 5.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Alignment Healthcare Trading Up 4.0%

ALHC traded up $0.83 during trading on Wednesday, hitting $21.75. The company’s stock had a trading volume of 5,508,648 shares, compared to its average volume of 2,608,866. The firm has a market capitalization of $4.35 billion, a P/E ratio of -181.25, a PEG ratio of 6.11 and a beta of 1.16. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $22.40. The stock’s fifty day moving average price is $18.87 and its 200-day moving average price is $16.68. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.03. The business had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. Alignment Healthcare’s revenue was up 43.5% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.14) earnings per share. Analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ALHC shares. UBS Group boosted their target price on Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday. JPMorgan Chase & Co. raised their price objective on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. Barclays upped their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a report on Friday, October 31st. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $21.55.

Institutional Investors Weigh In On Alignment Healthcare

A number of institutional investors have recently added to or reduced their stakes in the company. Larson Financial Group LLC bought a new stake in shares of Alignment Healthcare in the third quarter valued at $33,000. SBI Securities Co. Ltd. increased its holdings in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares during the last quarter. GAMMA Investing LLC raised its stake in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after acquiring an additional 987 shares during the period. KBC Group NV bought a new position in Alignment Healthcare during the second quarter worth about $44,000. Finally, Signaturefd LLC boosted its position in Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after purchasing an additional 2,215 shares during the period. 86.19% of the stock is owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.